CRNX
Crinetics Pharmaceuticals Inc
NASDAQ: CRNX · HEALTHCARE · BIOTECHNOLOGY
$84.95
+0.00% today
Updated 2026-09-01
Market cap
$9.01B
P/E ratio
—
P/S ratio
213.80x
EPS (TTM)
$-5.05
Dividend yield
—
52W range
$32 – $85
Volume
4.9M
Crinetics Pharmaceuticals Inc (CRNX) Insider transactions
Net insider activity
Net selling (5,024,247 shares)
Buy transactions
8
Sell transactions
92
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-01 | WIERENGA, WENDELL | Director | Sale | 17,500 | $64.77 | $1.13M |
| 2026-09-01 | WIERENGA, WENDELL | Director | Sale | 12,500 | $61.76 | $772000.00 |
| 2026-09-01 | WIERENGA, WENDELL | Director | Sale | 10,350 | $52.67 | $545134.50 |
| 2026-09-01 | WIERENGA, WENDELL | Director | Sale | 9,730 | $49.13 | $478034.90 |
| 2026-09-01 | WIERENGA, WENDELL | Director | Sale | 116,146 | $85.00 | $9.87M |
| 2026-09-01 | WIERENGA, WENDELL | Director | Sale | 5,925 | $85.00 | $503625.00 |
| 2026-09-01 | VIVALDI, COELHO ROGERIO | Director | Sale | 35,000 | $56.69 | $1.98M |
| 2026-09-01 | VIVALDI, COELHO ROGERIO | Director | Sale | 17,500 | $64.68 | $1.13M |
| 2026-09-01 | VIVALDI, COELHO ROGERIO | Director | Sale | 12,500 | $40.29 | $503625.00 |
| 2026-09-01 | VIVALDI, COELHO ROGERIO | Director | Sale | 10,350 | $52.67 | $545134.50 |
| 2026-09-01 | VIVALDI, COELHO ROGERIO | Director | Sale | 9,730 | $49.13 | $478034.90 |
| 2026-09-01 | VIVALDI, COELHO ROGERIO | Director | Sale | 8,750 | $66.71 | $583712.50 |
| 2026-09-01 | VIVALDI, COELHO ROGERIO | Director | Sale | 13,300 | $85.00 | $1.13M |
| 2026-09-01 | VIVALDI, COELHO ROGERIO | Director | Sale | 5,925 | $85.00 | $503625.00 |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 313,000 | $48.14 | $15.07M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 287,700 | $65.36 | $18.80M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 259,058 | $69.71 | $18.06M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 244,205 | $64.98 | $15.87M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 240,000 | $41.49 | $9.96M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 228,000 | $41.21 | $9.40M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 195,578 | $62.39 | $12.20M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 172,281 | $59.81 | $10.30M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 248,043 | $85.00 | $21.08M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 176,663 | $85.00 | $15.02M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 136,805 | $85.00 | $11.63M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 111,100 | $85.00 | $9.44M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 110,000 | $85.00 | $9.35M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 106,000 | $85.00 | $9.01M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 100,000 | $85.00 | $8.50M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 80,000 | $85.00 | $6.80M |
| 2026-09-01 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 1,000 | $85.00 | $85000.00 |
| 2026-09-01 | SCHILKE, TOBIN | Chief Financial & Infra. Ofcr. | Sale | 80,000 | $51.25 | $4.10M |
| 2026-09-01 | SCHILKE, TOBIN | Chief Financial & Infra. Ofcr. | Sale | 50,000 | $41.21 | $2.06M |
| 2026-09-01 | SCHILKE, TOBIN | Chief Financial & Infra. Ofcr. | Sale | 71,471 | $85.00 | $6.08M |
| 2026-09-01 | SCHILKE, TOBIN | Chief Financial & Infra. Ofcr. | Sale | 7,956 | $85.00 | $676260.00 |
| 2026-09-01 | OKEY, STEPHANIE | Director | Sale | 25,000 | $60.85 | $1.52M |
| 2026-09-01 | OKEY, STEPHANIE | Director | Sale | 17,500 | $64.77 | $1.13M |
| 2026-09-01 | OKEY, STEPHANIE | Director | Sale | 12,500 | $61.77 | $772125.00 |
| 2026-09-01 | OKEY, STEPHANIE | Director | Sale | 10,350 | $52.67 | $545134.50 |
| 2026-09-01 | OKEY, STEPHANIE | Director | Sale | 9,730 | $49.13 | $478034.90 |
| 2026-09-01 | OKEY, STEPHANIE | Director | Sale | 6,400 | $85.00 | $544000.00 |
| 2026-09-01 | OKEY, STEPHANIE | Director | Sale | 5,925 | $85.00 | $503625.00 |
| 2026-09-01 | NICHOLS, WESTON | Director | Sale | 17,500 | $64.68 | $1.13M |
| 2026-09-01 | NICHOLS, WESTON | Director | Sale | 12,500 | $61.76 | $772000.00 |
| 2026-09-01 | NICHOLS, WESTON | Director | Sale | 10,350 | $52.67 | $545134.50 |
| 2026-09-01 | NICHOLS, WESTON | Director | Sale | 9,730 | $49.13 | $478034.90 |
| 2026-09-01 | NICHOLS, WESTON | Director | Sale | 16,300 | $85.00 | $1.39M |
| 2026-09-01 | NICHOLS, WESTON | Director | Sale | 5,925 | $85.00 | $503625.00 |
| 2026-09-01 | KALOFONOS, ISABEL | Chief Commercial Officer | Sale | 97,500 | $44.41 | $4.33M |
| 2026-09-01 | KALOFONOS, ISABEL | Chief Commercial Officer | Sale | 55,000 | $41.21 | $2.27M |
| 2026-09-01 | KALOFONOS, ISABEL | Chief Commercial Officer | Sale | 34,000 | $85.00 | $2.89M |
| 2026-09-01 | KALOFONOS, ISABEL | Chief Commercial Officer | Sale | 1,669 | $85.00 | $141865.00 |
| 2026-09-01 | FUST, MATTHEW K | Director | Sale | 17,500 | $64.68 | $1.13M |
| 2026-09-01 | FUST, MATTHEW K | Director | Sale | 12,500 | $40.29 | $503625.00 |
| 2026-09-01 | FUST, MATTHEW K | Director | Sale | 10,350 | $52.67 | $545134.50 |
| 2026-09-01 | FUST, MATTHEW K | Director | Sale | 9,730 | $49.13 | $478034.90 |
| 2026-09-01 | FUST, MATTHEW K | Director | Sale | 2,092 | $83.09 | $173824.28 |
| 2026-09-01 | FUST, MATTHEW K | Director | Sale | 22,836 | $85.00 | $1.94M |
| 2026-09-01 | FUST, MATTHEW K | Director | Sale | 5,925 | $85.00 | $503625.00 |
| 2026-09-01 | DEARDORF, CAREN | Director | Sale | 35,000 | $65.70 | $2.30M |
| 2026-09-01 | DEARDORF, CAREN | Director | Sale | 17,500 | $64.68 | $1.13M |
| 2026-09-01 | DEARDORF, CAREN | Director | Sale | 12,500 | $40.29 | $503625.00 |
| 2026-09-01 | DEARDORF, CAREN | Director | Sale | 10,350 | $52.67 | $545134.50 |
| 2026-09-01 | DEARDORF, CAREN | Director | Sale | 9,730 | $49.13 | $478034.90 |
| 2026-09-01 | DEARDORF, CAREN | Director | Sale | 4,375 | $66.71 | $291856.25 |
| 2026-09-01 | DEARDORF, CAREN | Director | Sale | 16,300 | $85.00 | $1.39M |
| 2026-09-01 | DEARDORF, CAREN | Director | Sale | 5,925 | $85.00 | $503625.00 |
| 2026-09-01 | BETZ, STEPHEN F. | Chief Scientific Officer | Sale | 110,000 | $65.36 | $7.19M |
| 2026-09-01 | BETZ, STEPHEN F. | Chief Scientific Officer | Sale | 90,514 | $83.09 | $7.52M |
| 2026-09-01 | BETZ, STEPHEN F. | Chief Scientific Officer | Sale | 87,000 | $41.49 | $3.61M |
| 2026-09-01 | BETZ, STEPHEN F. | Chief Scientific Officer | Sale | 85,000 | $69.71 | $5.93M |
| 2026-09-01 | BETZ, STEPHEN F. | Chief Scientific Officer | Sale | 77,000 | $64.98 | $5.00M |
| 2026-09-01 | BETZ, STEPHEN F. | Chief Scientific Officer | Sale | 74,540 | $75.72 | $5.64M |
| 2026-09-01 | BETZ, STEPHEN F. | Chief Scientific Officer | Sale | 65,000 | $48.14 | $3.13M |
| 2026-09-01 | BETZ, STEPHEN F. | Chief Scientific Officer | Sale | 60,000 | $62.39 | $3.74M |
| 2026-09-01 | BETZ, STEPHEN F. | Chief Scientific Officer | Sale | 56,250 | $59.81 | $3.36M |
| 2026-09-01 | BETZ, STEPHEN F. | Chief Scientific Officer | Sale | 47,000 | $41.21 | $1.94M |
| 2026-09-01 | BETZ, STEPHEN F. | Chief Scientific Officer | Sale | 15,000 | $61.81 | $927150.00 |
| 2026-09-01 | BETZ, STEPHEN F. | Chief Scientific Officer | Sale | 79,650 | $85.00 | $6.77M |
| 2026-09-01 | BETZ, STEPHEN F. | Chief Scientific Officer | Sale | 58,286 | $85.00 | $4.95M |
| 2026-09-01 | BEDROSIAN, CAMILLE L | Director | Sale | 25,000 | $68.92 | $1.72M |
| 2026-09-01 | BEDROSIAN, CAMILLE L | Director | Sale | 17,500 | $64.68 | $1.13M |
| 2026-09-01 | BEDROSIAN, CAMILLE L | Director | Sale | 12,500 | $40.29 | $503625.00 |
| 2026-09-01 | BEDROSIAN, CAMILLE L | Director | Sale | 10,350 | $52.67 | $545134.50 |
| 2026-09-01 | BEDROSIAN, CAMILLE L | Director | Sale | 9,730 | $49.13 | $478034.90 |
| 2026-09-01 | BEDROSIAN, CAMILLE L | Director | Sale | 16,300 | $85.00 | $1.39M |
| 2026-09-01 | BEDROSIAN, CAMILLE L | Director | Sale | 5,925 | $85.00 | $503625.00 |
| 2026-08-20 | SCHILKE, TOBIN | Chief Financial & Infra. Ofcr. | Buy | 471 | — | — |
| 2026-08-07 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 6,542 | — | — |
| 2026-08-07 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 4,995 | — | — |
| 2026-08-07 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 4,422 | — | — |
| 2026-08-07 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Sale | 3,969 | — | — |
| 2026-08-07 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Buy | 6,542 | $15.29 | $100027.18 |
| 2026-08-07 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Buy | 4,995 | $20.02 | $99999.90 |
| 2026-08-07 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Buy | 4,422 | $22.61 | $99981.42 |
| 2026-08-07 | STRUTHERS, RICHARD SCOTT | Director, President & CEO | Buy | 3,969 | $25.19 | $99979.11 |
| 2026-07-02 | VIVALDI, COELHO ROGERIO | Director | Sale | 3,000 | $40.00 | $120000.00 |
| 2026-06-18 | WIERENGA, WENDELL | Director | Buy | 9,730 | — | — |
| 2026-06-18 | WIERENGA, WENDELL | Director | Buy | 5,925 | — | — |
| 2026-06-18 | VIVALDI, COELHO ROGERIO | Director | Buy | 9,730 | — | — |
Frequently asked questions
Are CRNX insiders buying or selling?
Over the transactions on record, CRNX insiders have been net sellers, with about $332.12M in stock sold across 92 sales, against 4 open-market purchases.
Does insider selling at CRNX mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which CRNX insiders are selling the most?
Recent selling is concentrated in a few names. STRUTHERS, RICHARD SCOTT accounts for the largest share on record, with about $200.58M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.